Apricot Capital
Venture capitalShanghai · Seed–Series A · 1 people tracked
Find your way into Apricot Capital
183 people in our graph share verified history with the Apricot Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Apricot Capital invests in early-stage medical innovation, with deep expertise in pharmaceutical R&D, medical device development, and life science tools. The firm leverages its management team's backgrounds in healthcare finance, pharmaceutical research, and clinical medicine to identify and support transformative innovations in drug development, medical devices, and diagnostic tools that address unmet clinical needs.
Source: firm website, verified Aug 5, 2026.
Team · 1 people
from public directories
What they invest in
from 13 of 21 portfolio companiesBiotech ×11Healthtech ×9Medical Devices ×7AI & Machine Learning ×4Advanced Manufacturing ×3Deep Tech ×2Digital Health ×2Cleantech ×1
HQs:China×9United States×2Singapore×1
Investments · 21 tracked
founders shown can be your intro pathCo-investorsDCP CapitalNextech Invest
Argo Biopharma is a clinical-stage biotechnology company developing siRNA-based therapeutics for chronic diseases using its proprietary RADS technology platform.
BiotechDigital HealthHealthtechMedical Devices
Dr. Shu(Co-founder, Chief Executive Officer)Dr. Shao(Co-founder, Chief Scientific Officer)
Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics.
AI & Machine LearningBiotechDeep Tech
Dr. Xuehai Liang(Founder)Dr. Yanfeng Wang(Founder & Chief Operating Officer)
Co-investors3E Bioventures CapitalF-Prime CapitalEight Roads VenturesGaorong VenturesLegend StarNew Alliance Capital
A company that develops enzyme catalysis platforms for pharmaceutical synthesis, using biological enzymes as catalysts to enable chemical reactions with lower toxicity and waste compared to traditional chemical synthesis methods.
Advanced ManufacturingBiotechCleantechDeep TechNew MaterialsBeijing, CN
ClinChoice operates a network of investigator sites that participate in clinical studies to support drug and device development.
BiotechHealthtechMedical DevicesPhiladelphia, US
Dr. John Balian(CEO)
Co-investorsDFJ DragonFundDraper AssociatesDraper DragonLegend CapitalLilly Asia VenturesSherpa Healthcare Partners
Co-investorsPuhua Capital
Geniebook offers an AI-powered online learning platform for school students in Singapore, providing personalized practice worksheets, live online classes following the MOE curriculum, on-demand teacher help, and automated marking.
AI & Machine LearningConsumerEdTechSaaS
Co-investorsLightspeed Venture PartnersEast Ventures
Junshi Biopharmaceuticals is a Chinese biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies, particularly in oncology immunotherapy, autoimmune diseases, chronic metabolic disorders, and infectious diseases.
BiotechHealthtechMedical DevicesShanghai, CN
MediLink Therapeutics develops innovative drugs including biologics, small molecule compounds, and antibody-drug conjugates for oncology and other therapeutic areas, with multiple programs in clinical development in China and the United States.
AI & Machine LearningBiotechHealthtechMedical DevicesShanghai, CN
Jiaqiang Cai(Co-founder, CSO and Co-CEO)Tony Xue
MicroPort is a medical device manufacturer that develops cardiovascular, orthopedic, and surgical solutions for healthcare providers and patients globally.
HealthtechMedical DevicesShanghai, CN
Co-investorsDraper Dragon
PharmCube builds a full-lifecycle pharmaceutical data platform paired with AI technology, supported by a medical and pharmacology team, offering data products, media content, and consulting services to companies in the pharmaceutical industry.
AI & Machine LearningBiotechData & Infrastructure
RemeGen is a biopharmaceutical company that develops and commercializes innovative biologic drugs, including telitacicept (a dual-target BLyS/APRIL biologic for systemic lupus erythematosus) and disitamab vedotin (a HER2-targeting antibody-drug conjugate for cancers such as urothelial carcinoma).
BiotechHealthtechYantai, CN
Wang Weidong(Co-founder)Jianmin Fang(Co-founder & CEO)
Co-investorsVivo Capital
Sheng Sheng SCM provides end-to-end pharmaceutical cold-chain logistics, including temperature-controlled transport and warehousing, for life sciences, biotech, drug development, and commercial finished-drug customers.
Advanced ManufacturingBiotechHealthtechLogistics & Supply ChainShanghai, CN
Co-investorsThe Innovation Space
TriApex provides contract research organization (CRO) services supporting pharmaceutical and biologics development, including preclinical studies, clinical trial design, regulatory strategy, and post-market safety monitoring.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesNanjing, CN
Co-investorsYuanBio Venture Capital
Portfolio news
latest coverage across their companiesArnatar Therapeutics · dakota.com · Aug 18, 2026
ClinChoice · trial.medpath.com · Jun 26, 2026
Frequently asked questions
- What stage does Apricot Capital invest at?
- Apricot Capital invests at the Seed, Series A stages.
- What sectors does Apricot Capital focus on?
- Apricot Capital focuses on Biotech, Consumer, EdTech, Healthtech, Medical Devices, PropTech.
- Where is Apricot Capital located?
- Apricot Capital is headquartered in Shanghai, CN.
- Does Apricot Capital lead rounds?
- Apricot Capital typically participates in rounds rather than leading them.
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
K3 Ventures presents itself as an investment platform focused on collaboration and partnership between founders and stakeholders, emphasizing trust, relevance, and long-term support.